Françoise Huguet

10PUBLICATIONS
81CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Microbial ecologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

|Mar 22, 2024
Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL.

Estelle Balducci, Mathieu Simonin, Nicolas Duployez

|Mar 07, 2024
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.

Yves Chalandon, Philippe Rousselot, Sylvie Chevret

|Oct 27, 2023
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.

Antoine Pinton, Lucien Courtois, Charlotte Doublet

|Sep 06, 2023
Vitamin C and D supplementation in acute myeloid leukemia.

Pierre Luc Mouchel, Emilie Bérard, Suzanne Tavitian

|Aug 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.

Rathana Kim, Hugo Bergugnat, Cédric Pastoret

Pageof 2

Frequent Collaborators

7 joint publications

Nicolas Boissel

5 joint publications

Rathana Kim

5 joint publications

Yves Chalandon

5 joint publications

Eric Delabesse

Françoise Huguet - Author Profile | JoVE Visualize